Susceptibility and Protective Immunity to Noroviruses
Susceptibility and Protective Immunity to Noroviruses
批准号:
7639960
负责人:
Ralph S Baric
金额:
$66.07万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2014-03-31
关键词:
AccountingAcuteAddressAllelesAnimal ModelAntibodiesAntigenic VariationAntigensB-Lymphocyte EpitopesBacterial GastroenteritisBindingBinding SitesBiochemistryCapsidCapsid ProteinsCarbohydratesCessation of lifeChargeChildCommunitiesCrystallographyDataDeceptive ImprintingDeveloped CountriesDeveloping CountriesDisease OutbreaksElderlyEpidemicEpitopesEvolutionExposure toFamily suidaeFoodGastroenteritisGenesGenotypeGnotobioticGrantHerd ImmunityHospitalizationHumanHydrogen BondingImmuneImmune responseImmunityImmunologic SurveillanceInfantInfectionIngestionLigand BindingMalnutritionMapsMeasuresMediatingModelingMolecularMolecular StructureMonoclonal AntibodiesMusMutagenesisMutationNorovirusNorwalk virusOpen Reading FramesPathogenesisPatternPeripheral Blood Mononuclear CellPersonsPredispositionPropertyProphylactic treatmentPublic HealthRNA VirusesReagentRecombinant DNARetirementSiteStomachStructureSurfaceT-LymphocyteTestingTimeTissuesTrefoil MotifVaccinatedVaccinesVariantViralVirusVirus DiseasesVirus-like particleWateraerosolizedantigen bindingbaseflufoodbornehuman monoclonal antibodiesimmune functionimmunogenicityin vivomortalitypathogenpreventpublic health relevancereceptorreceptor bindingresponsetherapeutic vaccinetissue tropismvaccination strategyvolunteer
中文摘要
描述(申请人提供):诺如病毒是全球食源性胃肠炎的最重要原因,在美国约85-96%的急性非细菌性胃肠炎的选定暴发是由诺如病毒引起的。被称为“胃流感”的退休社区疫情无处不在,可能会导致老年人1-2%的死亡率。根据衣壳序列将诺如病毒分为5个基因组组。基因群I(GI)和II(GII)几乎占所有人类感染的原因。每个基因组进一步划分为不同的基因类型。全球70%-80%的诺沃克病毒暴发是由Gi.4型病毒引起的。诺如病毒主要衣壳蛋白形成二十面体外壳,包含主要抗原决定簇,并与组织母细胞组抗原(HBGA)碳水化合物相互作用,后者是假定的进入受体。本研究探讨了免疫驱动的抗原漂移和欺骗性印迹作用下,诺如病毒衣壳的进化、结构和HBGA识别的分子机制。我们确定了替换菌株随时间进化的机制,识别了新的HBGA碳水化合物结合靶点,并逃避了高度渗透的宿主易感等位基因和保护性群体免疫。在确定突变、抗原变异、免疫原性、欺骗性印记、结构和HGBA结合之间的关系的同时,我们的跨学科团队同时在猪身上开发了一个强大的GII 4挑战模型,并表征了人类抗GI和GII株的单抗(MAb),为该领域的发展提供了关键试剂。公共卫生相关性:对于Noro Grant来说,诺如病毒是全球食源性胃肠炎的最重要原因,在美国约85-96%的急性非细菌性胃肠炎的选定暴发是由诺如病毒引起的。诺如病毒通过摄入受粪便污染的食物和水、暴露在受污染的表面、喷雾呕吐物和人与人之间的直接接触而传播。据估计,美国有2300万人感染诺沃克病毒,5万人住院,310例死亡病例,证明了诺沃克病毒对公共卫生的巨大意义。在发展中国家,反复感染可能会导致婴幼儿营养不良,并可能导致死亡。这一提议检验了诺沃克病毒株随时间进化以使用不同的细胞受体并避免宿主免疫监视的假设。如果这个模型是正确的,那么可以制定长期的毒株特异性保护性免疫和免疫预防措施,以防止当代毒株感染,为预防这种重要的人类病原体提供急需的疫苗接种策略。
英文摘要
DESCRIPTION (provided by applicant): Noroviruses are the most important cause of food-borne gastroenteritis worldwide and cause ~85-96% of selected outbreaks of acute non-bacterial gastroenteritis in the US. Heralded as the "stomach flu", retirement community outbreaks are pervasive and can result in 1-2% mortality rates in the elderly. Based on capsid sequences norovirus are divided into 5 genogroups. Genogroup I (GI) and II (GII) account for almost all human infections. Each genogroup is further divided into genotypes. The GII.4 genotype is the causative agent of 70-80% of all norovirus outbreaks worldwide. The norovirus major capsid protein forms an icosohedral shell, contains major antigenic determinants and interacts with histoblood group antigen (HBGA) carbohydrates, putative receptors for entry. This study investigates the molecular mechanisms governing norovirus capsid evolution, structure and HBGA recognition as a function of immune driven antigenic drift and deceptive imprinting. We identify the mechanisms by which replacement strains evolve over time, recognize new HBGA carbohydrate binding targets, and escape from highly penetrent host susceptibility alleles and protective herd immunity. While defining the relationships between mutation, antigenic variation, immunogenicity, deceptive imprinting, structure and HGBA binding, our interdisciplinary team simultaneously develops a robust GII.4 challenge model in swine and characterizes human monoclonal antibodies (mAb) to GI and GII strains, providing key reagents for advancing the field. PUBLIC HEALTH RELEVANCE: for Noro grant Noroviruses are the most important cause of food-borne gastroenteritis worldwide and cause ~85-96% of selected outbreaks of acute non-bacterial gastroenteritis in the US. Noroviruses are transmitted via ingestion of fecally contaminated food and water, exposure to contaminated surfaces, aerosolized vomitus and direct person-to-person contact. The tremendous public health significance of norovirus is evidenced by the estimated ~23,000,000 infections, 50,000 hospitalizations, and 310 fatal cases in the US. In developing nations, repeat infection likely contribute to malnutrition in infants and young children and may result in death. This proposal tests the hypothesis that Norovirus strains evolve over time to use varying cellular receptors and avoid host immune surveillance. If this model is correct, then long-term strain specific protective immunity and immune prophylaxis can be formulated to protect against contemporary strain infections providing a much needed vaccination strategy against this important human pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative Core
-
批准号:10513680
-
项目类别:
-
资助金额:$920.22万
-
财政年份:2022
-
负责人:Ralph S Baric
-
依托单位:
Development of direct-acting flavivirus inhibitors
-
批准号:10513687
-
项目类别:
-
资助金额:$395.75万
-
财政年份:2022
-
负责人:Ralph S Baric
-
依托单位:
Core B: Virology Core
-
批准号:10425027
-
项目类别:
-
资助金额:$215.31万
-
财政年份:2022
-
负责人:Ralph S Baric
-
依托单位:
Research Project 1: Coronavirus antiviral lead development and combination testing
-
批准号:10513684
-
项目类别:
-
资助金额:$508.76万
-
财政年份:2022
-
负责人:Ralph S Baric
-
依托单位:
RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE- AViDD CENTER (READDI-AC)
-
批准号:10513679
-
项目类别:
-
资助金额:$6548.32万
-
财政年份:2022
-
负责人:Ralph S Baric
-
依托单位:
Development of Antivirals against Filovirus Replication
-
批准号:10513686
-
项目类别:
-
资助金额:$379.6万
-
财政年份:2022
-
负责人:Ralph S Baric
-
依托单位:
Systems Immunogenetics of Emerging Coronavirus Infections in the Collaborative Cross
-
批准号:10180497
-
项目类别:
-
资助金额:$10.32万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
North Carolina Seronet Center for Excellence
-
批准号:10855051
-
项目类别:
-
资助金额:$295.01万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Project 1: Serological Correlates of SARS CoV2 Immunity and Disease
-
批准号:10688377
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
-
批准号:10264078
-
项目类别:
-
资助金额:$120.62万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
-
批准号:10265701
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV
-
批准号:10189984
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
North Carolina Seronet Center for Excellence
-
批准号:10222240
-
项目类别:
-
资助金额:$397.46万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Core A: Administrative Core
-
批准号:10222241
-
项目类别:
-
资助金额:$51.76万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Antibody Landscape following Human Norovirus Infection and Vaccination
-
批准号:10350601
-
项目类别:
-
资助金额:$73.72万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross
-
批准号:10271310
-
项目类别:
-
资助金额:$76.61万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
-
批准号:10265699
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2
-
批准号:10684696
-
项目类别:
-
资助金额:$119.78万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross
-
批准号:10686223
-
项目类别:
-
资助金额:$76.61万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
Respiratory Virus Vaccine and Adjuvant Exploration - Equipment Supplement
-
批准号:10242434
-
项目类别:
-
资助金额:$108.85万
-
财政年份:2020
-
负责人:Ralph S Baric
-
依托单位:
海外基金